News and media
Discover the latest news about motor neurone disease (MND) advocacy and research or visit our one-stop-shop for media, Media hub
Got a story to share? Tell us
about how MND has impacted your life.
Alison Mudie | 29/04/2016
As part of MND Week 2016, Australia's leading medical publication Australian Doctor today published a comprehensive feature article – How to Treat Motor Neurone Disease.
Rachel Rizk | 28/04/2016
MND Australia seeks an Executive Assistant who has passion and enthusiasm to support our national information, awareness, advocacy and research activities. Full job description.
Stephanie Williams | 19/04/2016
Research supported by the Motor Neurone Disease Research Institute of Australia, and led by Dr Kelly Williams and Associate Professor Ian Blair at Macquarie University, has found a new genetic cause of motor neurone disease (MND) and frontotemporal dementia (FTD).
Rachel Rizk | 5/04/2016
Do you work in a field relevant to health, disability, palliative care, aged care or community care professionals who support people with MND? We're looking for presenters for the National MND Conference to be held in Melbourne on 12 September 2016. Submit your abstract by 30 May.
Rachel Rizk | 29/03/2016
Find out about the economic and personal costs of MND and the influencing actions we are taking to champion the rights and needs of people impacted by MND – latest newsletter. #MNDcosts #MNDaction
Stephanie Williams | 22/03/2016
The MND Research Institute of Australia is pleased to announce the recipients of two 2016 Travel Grants.
Alison Mudie | 18/03/2016
Abstract submissions are now open for the 27th International Symposium on ALS/MND in Dublin, Republic of Ireland from 7-9 December 2016.
Alison Mudie | 10/03/2016
The MND Research Institute of Australia is pleased to announce three new PhD grants for commencement in 2016.
Alison Mudie | 2/03/2016
The first clinical trial of copper-ATSM as a potential treatment option for MND will start in 2016. Cu-ATSM therapy was developed in Australia, the first-in-man clinical study is being performed in Australia, and the sponsor is an Australian company (CMD).